US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist

9.000
-0.170-1.85%

Close Apr 26 16:00 ET

9.220
+0.220+2.44%

Post 18:17 ET

494.22MMarket Cap-3719P/E (TTM)

Astria Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-57.23%-68.45M

-183.55%-30.24M

-39.12%-14.26M

-6.31%-10.7M

-5.53%-13.25M

-44.38%-43.53M

-69.65%-10.66M

-32.26%-10.25M

-35.96%-10.06M

-44.09%-12.56M

Net income from continuing operations

-40.62%-72.89M

-136.82%-31.41M

-47.76%-17.73M

-11.69%-12.57M

26.99%-11.19M

73.41%-51.83M

-39.74%-13.26M

-52.42%-12M

-50.70%-11.25M

90.99%-15.32M

Operating gains losses

----

2,071.83%1.54M

--0

2,703.64%1.54M

Other non cash items

223.30%545K

128.65%163K

231.25%159K

-32.28%107K

246.84%116K

-100.27%-442K

-198.44%-569K

860.00%48K

2,533.33%158K

-100.05%-79K

Change In working capital

-191.16%-2.41M

-150.60%-1.06M

196.51%1.62M

608.24%432K

-3,796.74%-3.4M

168.27%2.65M

65.09%2.1M

142.64%545K

57.29%-85K

102.51%92K

-Change in prepaid assets

-189.92%-4.55M

-193.45%-3.23M

-61.13%-1.12M

983.61%661K

-630.06%-864K

-1,944.71%-1.57M

-193.46%-1.1M

66.91%-692K

-73.71%61K

-78.75%163K

-Change in payables and accrued expense

-24.66%2.74M

-12.02%2.33M

144.16%2.89M

40.00%-78K

-4,171.43%-2.39M

210.97%3.64M

290.69%2.65M

43.45%1.18M

68.97%-130K

98.72%-56K

-Change in other current liabilities

-206.27%-610K

-128.91%-159K

-381.82%-155K

-843.75%-151K

-866.67%-145K

184.29%574K

--550K

--55K

---16K

---15K

Cash from discontinued investing activities

Operating cash flow

-57.23%-68.45M

-183.55%-30.24M

-39.12%-14.26M

-6.31%-10.7M

-5.53%-13.25M

-44.38%-43.53M

-69.65%-10.66M

-32.26%-10.25M

-35.96%-10.06M

-44.09%-12.56M

Investing cash flow

Cash flow from continuing investing activities

180.81%135.05M

98.51%-2.02M

-100.21%-4K

-751.76%-57.92M

819.55%194.99M

-1,231.17%-167.13M

-246.62%-135.18M

1.95M

-6.8M

-202.47%-27.1M

Net PPE purchase and sale

72.53%-25K

48.39%-16K

93.10%-4K

--0

---5K

-333.33%-91K

---31K

---58K

---2K

--0

Net investment purchase and sale

180.87%135.08M

98.52%-2M

--0

-752.02%-57.92M

819.57%195M

-779.15%-167.04M

-246.54%-135.15M

--2.01M

---6.8M

-235.50%-27.1M

Cash from discontinued investing activities

Investing cash flow

180.81%135.05M

98.51%-2.02M

-100.21%-4K

-751.76%-57.92M

819.55%194.99M

-1,231.17%-167.13M

-246.62%-135.18M

--1.95M

---6.8M

-202.47%-27.1M

Financing cash flow

Cash flow from continuing financing activities

-38.92%88.4M

-26.93%87.98M

-99.55%110K

273K

37K

38.78%144.72M

708,117.65%120.4M

405,300.00%24.32M

Net common stock issuance

-39.17%87.98M

-26.90%87.98M

----

38.73%144.64M

--120.35M

----

Proceeds from stock option exercised by employees

400.00%420K

--0

223.53%110K

--273K

--37K

265.22%84K

194.12%50K

--34K

--0

Cash from discontinued financing activities

Financing cash flow

-38.92%88.4M

-26.93%87.98M

-99.55%110K

--273K

--37K

38.78%144.72M

708,117.65%120.4M

405,300.00%24.32M

--0

Net cash flow

Beginning cash position

-76.12%20.69M

160.04%119.97M

345.44%134.12M

331.04%202.46M

-76.12%20.69M

245.81%86.63M

-65.02%46.14M

-78.44%30.11M

-68.06%46.97M

245.81%86.63M

Current changes in cash

335.07%155.01M

318.98%55.72M

-188.31%-14.15M

-305.33%-68.34M

558.36%181.78M

-207.09%-65.94M

43.79%-25.45M

306.96%16.03M

-127.85%-16.86M

-132.51%-39.66M

End cash Position

749.25%175.69M

160.04%119.97M

345.44%134.12M

331.04%202.46M

-76.12%20.69M

-65.02%46.14M

-78.44%30.11M

-68.06%46.97M

Free cash flow

-56.95%-68.47M

-182.88%-30.25M

-38.37%-14.26M

-6.29%-10.7M

-5.57%-13.26M

-44.58%-43.62M

-70.14%-10.7M

-33.01%-10.31M

-35.99%-10.06M

-43.74%-12.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-57.23%-68.45M	-183.55%-30.24M	-39.12%-14.26M	-6.31%-10.7M	-5.53%-13.25M	-44.38%-43.53M	-69.65%-10.66M	-32.26%-10.25M	-35.96%-10.06M	-44.09%-12.56M
Net income from continuing operations	-40.62%-72.89M	-136.82%-31.41M	-47.76%-17.73M	-11.69%-12.57M	26.99%-11.19M	73.41%-51.83M	-39.74%-13.26M	-52.42%-12M	-50.70%-11.25M	90.99%-15.32M
Operating gains losses	----	----	----	----	----	2,071.83%1.54M	--0	--0	--0	2,703.64%1.54M
Other non cash items	223.30%545K	128.65%163K	231.25%159K	-32.28%107K	246.84%116K	-100.27%-442K	-198.44%-569K	860.00%48K	2,533.33%158K	-100.05%-79K
Change In working capital	-191.16%-2.41M	-150.60%-1.06M	196.51%1.62M	608.24%432K	-3,796.74%-3.4M	168.27%2.65M	65.09%2.1M	142.64%545K	57.29%-85K	102.51%92K
-Change in prepaid assets	-189.92%-4.55M	-193.45%-3.23M	-61.13%-1.12M	983.61%661K	-630.06%-864K	-1,944.71%-1.57M	-193.46%-1.1M	66.91%-692K	-73.71%61K	-78.75%163K
-Change in payables and accrued expense	-24.66%2.74M	-12.02%2.33M	144.16%2.89M	40.00%-78K	-4,171.43%-2.39M	210.97%3.64M	290.69%2.65M	43.45%1.18M	68.97%-130K	98.72%-56K
-Change in other current liabilities	-206.27%-610K	-128.91%-159K	-381.82%-155K	-843.75%-151K	-866.67%-145K	184.29%574K	--550K	--55K	---16K	---15K
Cash from discontinued investing activities
Operating cash flow	-57.23%-68.45M	-183.55%-30.24M	-39.12%-14.26M	-6.31%-10.7M	-5.53%-13.25M	-44.38%-43.53M	-69.65%-10.66M	-32.26%-10.25M	-35.96%-10.06M	-44.09%-12.56M
Investing cash flow
Cash flow from continuing investing activities	180.81%135.05M	98.51%-2.02M	-100.21%-4K	-751.76%-57.92M	819.55%194.99M	-1,231.17%-167.13M	-246.62%-135.18M	1.95M	-6.8M	-202.47%-27.1M
Net PPE purchase and sale	72.53%-25K	48.39%-16K	93.10%-4K	--0	---5K	-333.33%-91K	---31K	---58K	---2K	--0
Net investment purchase and sale	180.87%135.08M	98.52%-2M	--0	-752.02%-57.92M	819.57%195M	-779.15%-167.04M	-246.54%-135.15M	--2.01M	---6.8M	-235.50%-27.1M
Cash from discontinued investing activities
Investing cash flow	180.81%135.05M	98.51%-2.02M	-100.21%-4K	-751.76%-57.92M	819.55%194.99M	-1,231.17%-167.13M	-246.62%-135.18M	--1.95M	---6.8M	-202.47%-27.1M
Financing cash flow
Cash flow from continuing financing activities	-38.92%88.4M	-26.93%87.98M	-99.55%110K	273K	37K	38.78%144.72M	708,117.65%120.4M	405,300.00%24.32M	0	0
Net common stock issuance	-39.17%87.98M	-26.90%87.98M	----	----	----	38.73%144.64M	--120.35M	----	----	----
Proceeds from stock option exercised by employees	400.00%420K	--0	223.53%110K	--273K	--37K	265.22%84K	194.12%50K	--34K	--0	--0
Cash from discontinued financing activities
Financing cash flow	-38.92%88.4M	-26.93%87.98M	-99.55%110K	--273K	--37K	38.78%144.72M	708,117.65%120.4M	405,300.00%24.32M	--0	--0
Net cash flow
Beginning cash position	-76.12%20.69M	160.04%119.97M	345.44%134.12M	331.04%202.46M	-76.12%20.69M	245.81%86.63M	-65.02%46.14M	-78.44%30.11M	-68.06%46.97M	245.81%86.63M
Current changes in cash	335.07%155.01M	318.98%55.72M	-188.31%-14.15M	-305.33%-68.34M	558.36%181.78M	-207.09%-65.94M	43.79%-25.45M	306.96%16.03M	-127.85%-16.86M	-132.51%-39.66M
End cash Position	749.25%175.69M	749.25%175.69M	160.04%119.97M	345.44%134.12M	331.04%202.46M	-76.12%20.69M	-76.12%20.69M	-65.02%46.14M	-78.44%30.11M	-68.06%46.97M
Free cash flow	-56.95%-68.47M	-182.88%-30.25M	-38.37%-14.26M	-6.29%-10.7M	-5.57%-13.26M	-44.58%-43.62M	-70.14%-10.7M	-33.01%-10.31M	-35.99%-10.06M	-43.74%-12.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall